Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABALOPARATIDE for Bone density decreased: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where ABALOPARATIDE was used for Bone density decreased.

Most Reported Side Effects for ABALOPARATIDE

Side Effect Reports % Deaths Hosp.
Headache 4,048 17.3% 0 92
Nausea 3,134 13.4% 1 84
Dizziness 3,005 12.9% 0 99
Fatigue 2,637 11.3% 0 63
Heart rate increased 2,092 9.0% 0 40
Palpitations 1,730 7.4% 0 50
Arthralgia 1,711 7.3% 0 41
Bone pain 1,360 5.8% 0 26
Back pain 1,229 5.3% 0 37
Pain 1,191 5.1% 0 48
Product dose omission issue 1,006 4.3% 0 78
Injection site bruising 946 4.1% 0 20
Product dose omission 938 4.0% 1 64
Product quality issue 914 3.9% 1 26
Pain in extremity 912 3.9% 0 26

Other Indications for ABALOPARATIDE

Osteoporosis postmenopausal (7,932) Senile osteoporosis (7,272) Osteoporosis (4,420) Product used for unknown indication (3,174) Osteoporotic fracture (658) Pathological fracture (191) Illness (179) Rheumatoid arthritis (130) Osteoarthritis (71) Bone density abnormal (70)

Other Drugs Used for Bone density decreased

ALENDRONATE (285) DENOSUMAB (169) TERIPARATIDE (159) ZOLEDRONIC ACID (104) IBANDRONATE (54) RISEDRONATE (42) PAMIDRONATE (39) ALENDRONATE\CHOLECALCIFEROL (29) ROMOSOZUMAB-AQQG (23) ALENDRONIC ACID (22)

Related Pages

ABALOPARATIDE Full Profile All Bone density decreased Drugs ABALOPARATIDE Demographics ABALOPARATIDE Timeline